Published: May 7th 2024 | Updated: May 21st 2024
FDA accepts BLA for subcutaneous nivolumab in solid tumors
Published: October 28th 2024 | Updated: October 31st 2024
Vaginal estrogen for GSM not associated with major adverse cardiovascular events
Published: October 25th 2024 | Updated: October 31st 2024
OASIS: Efficacy of Revi System for urgency incontinence maintained at 2 years
Published: July 29th 2024 | Updated: October 31st 2024
Study highlights need for improved enrollment, reporting in urolithiasis trials
Published: July 10th 2024 | Updated: October 31st 2024
AUA, GURS, SUFU amend guideline for incontinence after prostate treatment
Published: August 6th 2024 | Updated: October 31st 2024
Investigators link genomic and clinical data to real-world outcomes in prostate cancer